These patients comprise 95% of AD cases, although about 1% are attributed to autosomal dominant mutations in amyloid metabolism-related genes, e.g., beta amyloid precursor protein (βAPP-chromosome 21), presenilin 1 (PS1-chromosome 14), and presenilin 2 genes (PS2-chromosome 1) [6]. Here, APP is linked to Alzheimer disease.